Adithan Chandrasekaran

<i>CYP2C9</i> and <i>CYP2C19</i> genetic polymorphisms: frequencies in the south Indian population

Rosemary Jose, Adithan Chandrasekaran, Soya S. Sam et al. · Fundamental and Clinical Pharmacology · 2004 · 109 citations

Life Sciences, Genetics, Molecular Genetics +14

Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

Dhakchinamoorthi Krishna Kumar, Deepak Gopal Shewade, Marie‐Anne Loriot et al. · European Journal of Clinical Pharmacology · 2013 · 64 citations

Veterinary Medicine, Genetics, Pharmacology +17

A Single-Nucleotide Polymorphism in the MDR1 Gene as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer

Joseph George, Kadambari Dharanipragada, Adithan Chandrasekaran et al. · Clinical Breast Cancer · 2009 · 51 citations

Medicine, Genetics, Oncology +14

Body mass index contributes to sympathovagal imbalance in prehypertensives

Gopal Krushna Pal, Adithan Chandrasekaran, Ananthanarayanan Palghat Hariharan et al. · BMC Cardiovascular Disorders · 2012 · 44 citations · Full text

Medicine, Cardiology, Physiology +17

Ethics of genomic research

Adithan Chandrasekaran, Jayanthi Mathaiyan, Sanish Davis · Perspectives in Clinical Research · 2013 · 39 citations · Full text

Public Health, Biology, Genetics +12